Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19983317 | 1.00 | MEN1 (0.42) | MEN1KMT2AALDH1A1TDP1POLB | |
| SCHEMBL19983229 | 0.84 | MEN1 (0.44) | MEN1KMT2AALDH1A1TDP1POLB | |
| SCHEMBL19983230 | 0.84 | MEN1 (0.44) | MEN1KMT2AALDH1A1TDP1POLB | |
| SCHEMBL19982937 | 0.81 | CTSB (0.51) | — | |
| SCHEMBL19982935 | 0.81 | CTSB (0.51) | — | |
| SCHEMBL28344129 | 0.80 | MEN1 (0.44) | MEN1KMT2AALDH1A1TDP1ITGB3 | |
| SCHEMBL19983275 | 0.80 | MEN1 (0.44) | MEN1KMT2AALDH1A1TDP1ITGB3 | |
| SCHEMBL17646306 | 0.80 | MEN1 (0.44) | MEN1KMT2AALDH1A1TDP1ITGB3 | |
| SCHEMBL25659953 | 0.79 | TDP1 (0.44) | MEN1KMT2AALDH1A1TDP1ITGB3 | |
| SCHEMBL19982985 | 0.78 | MEN1 (0.52) | MEN1KMT2AALDH1A1TDP1ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018053353-A1 | KETONE INHIBITORS OF LYSINE GINGIPAIN | Cortexyme, Inc. (US) | 2018-03-22 | — | — | WO | disclosed |